最新数据显示,今明两年将有超过200万吨/年的己内酰胺项目投产,其中80%集中在中国大陆及台湾地区。同时,欧洲地区一些老装置将陆续关停。一增一减之间,亚洲地区己内酰胺的进口依存度有望大大下降,欧洲等传统出口地区将受到较大影响,全球己内酰胺贸易格局即将大改变。据统计,2011年世界己内酰胺的总消费量约为406.0万吨,同期己内酰胺总生产能力约491.0万吨,其中亚洲约占总产能的38.1%。消费主要集中在亚洲、北美和西欧地区,其中亚洲地区消费量约 According to the latest statistics, more than 2 million tons / year of caprolactam will be put into operation in the next two years, 80% of which are concentrated in mainland China and Taiwan. At the same time, some old devices in Europe will gradually be shut down. Between one and one increases and decreases, the import dependence of caprolactam in Asia is expected to decline significantly. The traditional export areas such as Europe will be greatly affected, and the global trade pattern of caprolactam is about to change dramatically. According to statistics, the total world caprolactam consumption in 2011 was about 4.06 million tons. In the same period, the total caprolactam production capacity was 4.19 million tons, of which Asia accounted for about 38.1% of the total capacity. Consumption is mainly concentrated in Asia, North America and Western Europe, of which about consumption in Asia